Mesenbio Seed (2024, $1M) Funding Round Information - Funding ...

Mesenbio Seed (2024, $1M) Funding Round Information - Funding ...

5 days from now

Get information on funding, investors, industries, and more for Mesenbio Seed (2024, $1M). See Mesenbio Seed (2024, $1M) company profile and funding data.

seedtable.com

Seed Round - Mesenbio - 2024-01-09 - Crunchbase Funding …

5 days from now

Mesenbio raised $1779681 on 2024-01-09 in Seed Round. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. Pricing. Resources. Log In. Funding …

crunchbase.com

Mesenbio - Company Profile - Tracxn

5 days from now

Oct 25, 2024  · Its latest funding round was a Seed round on Jan 09, 2024 for $1.78M. 2 investors participated in its latest round, lead by DSW Ventures, . List of recent funding rounds of …

tracxn.com

Mesenbio - Raised $1.78M Funding From 2 Investors - Tracxn

5 days from now

Nov 4, 2024  · PiktID - Klagenfurt based, raised a funding in Seed round held on 27 Sep, 2024. Vedantu - Bengaluru based, raised a funding of $2.3M in Series E round held on 27 Sep, …

tracxn.com

Mesenbio Company Profile 2024: Valuation, Funding & Investors

5 days from now

Information on valuation, funding, cap tables, investors, and executives for Mesenbio. ... 09-Jan-2024: $1.78M: Completed: Pre-Clinical Trials: ... How much funding has Mesenbio raised over …

pitchbook.com

Mesenbio, University Of York Spin-out, Raises £1.4m

5 days from now

Jan 9, 2024  · Mesenbio, a University of York spin-out firm that is developing a novel treatment for arthritis created from engineered human stem cells, has raised £1.4 million in an investment …

northernfinancialreview.com

Mesenbio Raises £1.4M In Funding - FinSMEs

5 days from now

Jan 9, 2024  · Mesenbio, a University of York (UK) spin-out that is developing a novel treatment for arthritis created from engineered human stem cells, raised £1.4m in funding.. The round was …

finsmes.com

DSW Ventures And NGBio Lead £1.4m Investment Into University …

5 days from now

Jan 9, 2024  · Mesenbio, a University of York spin-out that is developing a novel treatment for arthritis created from engineered human stem cells, has raised £1.4m in an investment round …

dsw.vc

Fierce Biotech Fundraising Tracker 2024

5 days from now

3 days ago  · Series: Seed & A Amount: $100 million Investors: ... Mirador Therapeutics has secured a massive $400 million series A funding round—the biggest of 2024 thus far. The new …

fiercebiotech.com

Innovative Approach To Combat Arthritis: Mesenbio's

5 days from now

Jan 15, 2024  · Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This funding round, co-led by DSW …

biopharmatrend.com

Mesenbio Secured £1,400,000 In A Fantastic Undefined Funding …

5 days from now

Jan 9, 2024  · Mesenbio, a spin-out company from the University of York in the UK, has secured £1.4m in funding for the development of a revolutionary arthritis treatment. The funding round, …

startupmag.co.uk

University Spin-out Raises £1.4m For Novel Arthritis Treatment

5 days from now

Jan 9, 2024  · Mesenbio, a University of York spin-out developing a treatment for arthritis using engineered human stem cells, has raised £1.4m in a funding round co-led by DSW Ventures …

thebusinessdesk.com

University Spin-out Bags £1.4m For Arthritis Treatment

5 days from now

Jan 10, 2024  · Mesenbio, a University of York spin-out that is developing a novel treatment for arthritis created from engineered human stem cells, has raised £1.4m in investment. The …

businesscloud.co.uk

Layers Company Profile 2024: Valuation, Funding & Investors

5 days from now

Information on valuation, funding, cap tables, investors, and executives for Layers. Use the PitchBook Platform to explore the full profile. ... Seed Round: 18-Nov-2024: $1M: Completed: …

pitchbook.com